Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs)
$91.55
neg -2.24
-2.39%
Today's Range: 91.25 - 93.37 | GILD Avg Daily Volume: 11,379,900
Last Update: 07/31/14 - 4:00 PM EDT
Volume: 13,379,754
YTD Performance: 24.89%
Open: $93.00
Previous Close: $93.79
52 Week Range: $55.96 - $94.34
Oustanding Shares: 1,535,682,107
Market Cap: 142,803,079,130
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 11 15 15 16
Moderate Buy 1 1 2 2
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.36 1.28 1.32 1.30
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 19.91
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
19.91 20.90 28.85
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
19.49% 51.94% 342.82%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.50 0.41 0.12
Net Income 18.80 0.06 0.02
EPS 121.60 0.18 0.06
Earnings for GILD:
EBITDA 4.87B
Revenue 11.20B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.40 $1.91 $6.21 $8.47
Number of Analysts 3 3 4 4
High Estimate $1.64 $2.66 $7.76 $9.88
Low Estimate $1.22 $1.52 $5.51 $7.31
Prior Year $0.50 $0.52 $1.92 $6.21
Growth Rate (Year over Year) 180.67% 267.31% 223.18% 36.46%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Where what the Fed does allegedly determines everything.
Something worrisome has me fretting more than I have in a while.
This week's earnings gave me a little more confidence about market valuation.
Bullish
Jul 24, 2014 | 7:56 AM EDT
GILD estimates were raised through 2015, Leerink Swann said. Company boosted its guidance, given higher Sovaldi sales. Outperform ratin...
McDonald's and GlaxoSmithKline are fighting against major turns of the tide.

Digging for Hidden Gems Real Money Pro($)

Behold, my long list of fresh ideas this earnings season.

Time to Deliver Real Money Pro($)

Of the more than 100 companies reporting earnings this week, here are some I will be watching.

Removing SanDisk from Top Five Real Money Pro($)

I will book my 50% gain and look for the next good idea.
If you're worried about these moves, it's time to cash out.
The market's latest report card would be a true horror show.

Columnist Conversations

Volume in the SPY today was nearly double its 50 day average of volume. (The graph at the bottom of the chart ...
Is this the biotech revolution or the biotech bust? View Small Cap Biotechs Like Never Before: Transparency is...
Market got beat like a rented mule today as equities posted their second worst day of the year. Geopolitical ...
down 302 now, at 16577 the dow 30 is unchanged for 2014. roll the media hype!

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.